Skip to search formSkip to main contentSkip to account menu

ingramon

Known as: anti-inflammatory peptide X 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Peptide Fragments

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Ingramon, a Peptide Inhibitor of MCP-1 Chemokine, Reduces Migration of Blood Monocytes Stimulated by Glioma-Conditioned Medium
Malignant gliomas are most common and fatal primary brain tumors. In addition to neoplastic cells, the tumor tissue contains… 
2011
2011
Synthetic peptide fragment (65–76) of monocyte chemotactic protein-1 (MCP-1) inhibits MCP-1 binding to heparin and possesses anti-inflammatory activity in stable angina patients after coronary…
Objective and designThe peptide from C-terminal domain of MCP-1 (Ingramon) has been shown to inhibit monocyte migration and… 
2010
2010
[Effect of the anti-inflammatory peptide preparation ingramon on the blood levels of acute-phase proteins and chemokines in patients after coronary stenting].
AIM To study the effect of the anti-inflammatory peptide preparation ingramon on the peripheral blood levels of inflammatory… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)